Prevalence of clinically actionable disease variants in exceptionally long-lived families
Open Access
- 10 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medical Genomics
- Vol. 13 (1), 1-7
- https://doi.org/10.1186/s12920-020-0710-5
Abstract
Phenotypic expression of pathogenic variants in individuals with no family history of inherited disorders remains unclear. We evaluated the prevalence of pathogenic variants in 25 genes associated with Mendelian-inherited disorders in 3015 participants from 485 families in the Long Life Family Study (LLFS). Boot-strapping and Fisher’s exact test were used to determine whether allele frequencies in LLFS were significantly different from the allele frequencies reported in publicly available genomic databases. The proportions of pathogenic autosomal dominant mutation carriers in BRCA1 and SDHC in LLFS study participants were similar to those reported in publicly available genomic databases (0.03% vs. 0.0008%, p = 1 for BRCA1, and 0.08% vs. 0.003%, p = 0.05 for SDHC). The frequency of carriers of pathogenic autosomal recessive variants in CPT2, ACADM, SUMF1, WRN, ATM, and ACADVL were also similar in LLFS as compared to those reported in genomic databases. The lack of clinical disease among LLFS participants with well-established pathogenic variants in BRCA1 and SDHC suggests that penetrance of pathogenic variants may be different in long lived families. Further research is needed to better understand the penetrance of pathogenic variants before expanding large scale genomic testing to asymptomatic individuals.Keywords
Funding Information
- National Institute on Aging (U01-AG023712, U01-AG23744, U01-AG023746, U01-AG023749, and U01-AG023755)
This publication has 41 references indexed in Scilit:
- Deleterious- and Disease-Allele Prevalence in Healthy Individuals: Insights from Current Predictions, Mutation Databases, and Population-Scale ResequencingAmerican Journal of Human Genetics, 2012
- Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevityProceedings of the National Academy of Sciences of the United States of America, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyHuman Mutation, 2010
- A Family Longevity Selection Score: Ranking Sibships by Their Longevity, Size, and Availability for StudyAmerican Journal of Epidemiology, 2009
- Detection of nonneutral substitution rates on mammalian phylogeniesGenome Research, 2009
- Sequence-non-specific effects of RNA interference triggers and microRNA regulatorsNucleic Acids Research, 2009
- Identification of deleterious mutations within three human genomesGenome Research, 2009
- ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007Genetics in Medicine, 2008
- Distribution and intensity of constraint in mammalian genomic sequenceGenome Research, 2005